ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation
Shannen J. Deconinck, Christoph Nix, Svenja Barth, Eveline Bennek‐Schöpping, Antoine Rauch, An‐Sofie Schelpe, Elien Roose, Hendrik B. Feys, Inge Pareyn, Aline Vandenbulcke, Joshua Muia, Christophe Vandenbriele, Sophie Susen, Bart Meyns, Claudia Tersteeg, Steven Jacobs, Simon F. De Meyer, Karen Vanhoorelbeke
Topics & Concepts
ADAMTS13Von Willebrand factorHemostasisDisintegrinThrombospondinPlateletMetalloproteinaseADAMTSProteolysisChemistryMonoclonal antibodyThrombotic thrombocytopenic purpuraMedicineImmunologyMatrix metalloproteinaseInternal medicineAntibodyBiochemistryEnzymeComplement system in diseasesPlatelet Disorders and TreatmentsMechanical Circulatory Support Devices